Role of IFN-γ-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 957-964

  Bodaghi, Bahrain ^a,c   Goureau, Olivier ^b   Zipeto, Donato ^a   Laurent, Lysiane ^a   Virelizier, Jean Louis ^a   Michelson, Susan ^a  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c Unité d'Immunologie Virale   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; NITRIC OXIDE SYNTHASE;

ARTICLE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; ENZYME INDUCTION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INFECTION RESISTANCE; INTERFERON PRODUCTION; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINITIS; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CYTOKINES; CYTOMEGALOVIRUS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PIGMENT EPITHELIUM OF EYE; TRYPTOPHAN; TRYPTOPHAN OXYGENASE; VIRUS REPLICATION;

EID: 0033555723     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Grisanti, S., M. Ishioka, M. Kosiewicz, L. Q. Jiang, J. W. Streilein, G. A. Wilbanks, A. Taylor, and S. Cousins. 1997. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants. Invest. Ophthalmol. Vis. Sci. 38:1619.
2. Wilbanks, G. A., M. Mammolemi, and J. W. Streilein. 1992. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur. J. Immunol. 22:165.
3. Jiang, L. Q., M. Jorquera, and J. W. Streilein. 1993. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest. Ophthalmol. Vis. Sci. 34:3347.
4. Griffith, T. S., and T. A. Ferguson. 1997. The role of FasL-induced apoptosis in immune privilege. Immunol. Today 18:240.
5. Gabrielian, K., R. Osusky, B. D. Sippy, S. J. Ryan, and D. R. Hinton. 1994. Effect of TGF-β on interferon-γ-induced HLA-DR expression in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 35:4253.
6. Ferguson, T. A., and T. S. Griffith. 1997. A vision of cell death: insights into immune privilege. Immunol. Rev. 156:167.
7. Bok, D. 1993. The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci. (Suppl) 17:189.
8. Hoover, D. R., Y. Peng, A. Saah, R. Semba, R. R. Detels, C. R. Rinaldo, and J. P. Phair. 1996. Occurrence of cytomegalovirus retinitis after human immuno-deficiency virus immunosuppression. Arch. Ophthalmol. 114:821.
9. Jabs, D. A., C. Enger, and J. G. Bartlett. 1989. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch. Ophthalmol. 107:75.
10. Miceli, M. V., D. A. Newsome, L. C. Novak, and R. W. Beuerman. 1989. Cytomegalovirus replication in cultured human retinal pigment epithelial cells. Curr. Eye Res. 8:835.
11. Henderly, D. E., L. R. Atalla, W. R. Freeman, and N. A. Rao. 1988. Demonstration of cytomegalovirus retinitis by in situ DNA hybridization. Retina 8:177.
12. Burd, E. M., J. S. Pulido, D. G. Puro, and W. J. O'Brien. 1996. Replication of human cytomegalovirus in human retinal glial cells. Invest. Ophthalmol. Vis. Sci. 37:1957.
13. Detrick, B., J. Rhame, Y. Wang, C. N. Nagineni, and J. J. Hooks. 1996. Cytomegalovirus replication in human retinal pigment epithelial cells: altered expression of viral early proteins. Invest. Ophthalmol. Vis. Sci. 37:814.
14. Tay-kearney, M. L., C. Enger, R. D. Semba, W. Royal, J. P. Dunn, and D. A. Jabs. 1997. T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients. J. Infect. Dis. 176:790.
15. Mondino, B. J., Y. Sidikaro, F. J. Mayer, and H. L. Sumner. 1990. Inflammatory mediators in the vitreous humor of AIDS patients with retinitis. Invest. Ophthalmol. Vis. Sci. 31:798.
16. Hofman, F. M., and D. R. Hinton. 1992. Tumor necrosis factor-α in the retina in acquired immune deficiency syndrome. Invest. Ophthalmol. Vis. Sci. 33:1829.
17. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749.
18. Castelli, J. C., B. A. Hassel, K. A. Wood, X. L. Li, K. Amemiya, M. C. Dalakas, P. F. Torrence, and R. J. Youle. 1997. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5a system. J. Exp. Med. 186:967.
19. Haagmans, B. L., A. J. van den Eertwegh, E. Claassen, M. C. Horzinek, and V. E. Schijns. 1994. Tumor necrosis factor-α production during cytomegalovirus infection in immunosuppressed rats. J. Gen. Virol. 75:779.
20. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U. H. Koszinowski. 1992. [Gamma] interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1977.
21. Lucin, P., S. Jonjic, M. Messerle, B. Polic, H. Hengel, and U. H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-γ and tumor necrosis factor. J. Gen. Virol. 75:101.
22. Yamamoto, N., K. Shimokata, K. Maeno, and Y. Nishiyama. 1987. Effect of recombinant human interferon γ against human cytomegalovirus. Arch. Virol. 94:323.
23. Malina, H. Z., and X. D. Martin. 1993. Indoleamine 2,3-dioxygenase activity in the aqueous humor, iris/ciliary body, and retina of the bovine eye. Graefe's Arch. Clin. Exp. Ophthalmol. 231:482
24. Nagineni, C. N., K. Pardhasaradhi, M. C. Martins, B. Detrick, and J. J. Hooks. 1996. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 64:4188.
25. Goureau, O., D. Hicks, and Y. Courtois. 1994. Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. Biochem. Biophys. Res. Commun. 198:120.
26. Taylor, M. W., and G. S. Feng. 1991. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5:2516.
27. Pfefferkorn, E. R. 1984. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81:908.
28. Carlin, J. M., E. C. Borden, and G. I. Byrne. 1989. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J. Interferon Res. 9:329.
29. Shoshkes Reiss, C., and T. Komatsu. 1998. Does nitric oxide play a role in viral infections? J. Virol. 72:4547.
30. Lin, Y. L., Y. L. Huang, S. H. Ma, C. T. Yeh, S. Y. Chiou, L. K. Chen, and C. L. Liao. 1997. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J. Virol. 71:5227.
31. Karupiah, G., Q. W. Xie, R. M. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:1445.
32. Tucker, P. C., D. E. Griffin, S. Choi, N. Bui, and S. Wesselingh. 1996. Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J. Virol. 70:3972.
33. Melkova, Z., and M. Esteban. 1995. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J. Immunol. 155:5711.
34. Lowenstein, C. J., S. L. Hill, A. Lafond-Walker, J. Wu, G. Allen, M. Landavere, N. R. Rose, and A. Herskowitz. 1996. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97:1837.
35. Zaragoza, C., C. J. Ocampo, M. Saura, A. McMillan, and C. J. Lowenstein. 1997. Nitric oxide inhibition of coxsackievirus replication in vitro. J. Clin. Invest. 100: 1760.
36. Becquet, F., Y. Courtois, and O. Goureau. 1997. Nitric oxide in the eye: multi-faceted roles and diverse outcome. Surv. Ophthalmol. 42:71.
37. Dighiero, P., I. Reux, J. J. Hauw, A. M. Fillet, Y. Courtois, and O. Goureau. 1994. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci. Lett. 166:31.
38. Nash, M. S., and N. N. Osborne. 1995. Pertussis toxin-sensitive melatonin receptors negatively coupled to adenylate cyclase associated with cultured human and rat retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 36:95.
39. Alcami, J., C. V. Paya, J. L. Virelizier, and S. Michelson. 1993. Antagonistic modulation of human cytomegalovirus replication by transforming growth factor β and basic fibroblastic growth factor J. Gen. Virol. 74:269.
40. Ho, W. Z., R. Cherukuri, S. D. Ge, J. R. Cutilli, L. Song, S. Whitko, and S. D. Douglas. 1993. Centrifugal enhancement of human immunodeficiency virus type I infection and human cytomegalovirus gene expression in human primary monocytes/macrophages in vitro. J. Leukocyte Biol. 53:208.
41. Beatty, W. L., T. A. Belanger, A. A. Desai, R. P. Morrison, and G. I. Byrne. 1994. Tryptophan depletion as a mechanism of γ interferon-mediated chlamydial persistence. Infect. Immun. 62:3705.
42. Brown, R. R., Y. Ozaki, S. P. Datta, E. C. Borden, P. M. Sondel, and D. G. Malone. 1991. Implications of interferon-induced tryptophan catabolism in cancer, autoimmune diseases and AIDS. Adv. Exp. Med. Biol. 294:425.
43. Takikawa, O., T. Kuroiwa, F. Yamazaki, and R. Kido. 1988. Mechanism of interferon-γ action: characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-γ and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263:2041.
44. Mazeron, M. C., G. Jahn, and B. Plachter. 1992. Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epilope encoded by exon 2 of the major immediate early gene. J. Gen. Virol. 73:2699.
45. Michelson, S., M. Tardy-Panit, and O. Barzu. 1984. Properties of a human cytomegalovirus-induced protein kinase. Virology 134:259.
46. Amadéi, C., M. Tardy-Panit, P. Couillin, M. Coulon, N. Cabau, A. Boué, and S. Michelson. 1983. Kinetic study of the development and localization of human cytomegalovirus-induced antigens using monoclonal antibodies. Ann. Virol. (Inst. Pasteur) 134E:165.
47. Jahn, G., T. Kouzarides, M. Mach, B. C. Scholl, B. Plachter, B. Traupe, E. Preddie, S. C. Satchwell, B. Fleckenstein, and B. G. Barrell. 1987. Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. J. Virol. 61:1358.
48. Michelson, S., F. Horodniceanu, M. Kress, and M. Tardy-Panit. 1979. Human cytomegalovirus-induced immediate early antigens: analysis in sodium dodecyl sulfate-polyacrylamide gel electrophoresis after immunoprecipitation. J. Virol. 32:259.
49. Riddell, S. R., and P. D. Greenberg. 1997. T cell therapy of human CMV and EBV infection in immunocompromised hosts. Rev. Med. Virol. 7:181.
50. Gallant, J. E., R. D. Moore, D. D. Richman, J. Keruly, and R. E. Chaisson. 1992. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J. Infect. Dis. 166:1223.
51. Duker, J. S., and M. S. Blumenkranz. 1991. Diagnosis and management of the acute retinal necrosis (ARN) syndrome. Surv. Ophthalmol. 35:327.
52. Holland, G. N. 1994. Standard diagnostic criteria for the acute retinal necrosis syndrome: Executive Committee of the American Uveitis Society Am. J. Ophthalmol. 117:663.
53. Nakamura, K., Y. Eizuru, and Y. Minamishima. 1988. Effect of natural human interferon-β on the replication of human cytomegalovirus. J. Med. Virol. 26:363.
54. Michelson, S. 1998. Mechanisms of immunosuppression by human cytomegalovirus. In CMV-Related Immunopathology. M. Scholz, H. F. Rabenau, H. W. Doerr, and J. Cinatl, Jr., eds. Karger, Basel, pp. 12-28.
55. Haagmans, B. L., F. S. Stals, P. H. van der Meide, C. A. Bruggeman, M. C. Horzinek, and V. E. Schijns. 1994. Tumor necrosis factor α promotes replication and pathogenicity of rat cytomegalovirus. J. Virol. 68:2297.
56. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U. H. Koszinowski. 1993. Participation of endogenous tumor necrosis factor α in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:2215.
57. Haagmans, B. L., P. H. van der Meide, F. S. Stals, A. J. van den Eertwegh, E. Claassen, C. A. Bruggeman, M. C. Horzinek, and V. E. Schijns. 1994. Suppression of rat cytomegalovirus replication by antibodies against γ interferon. J. Virol. 68:2305.
58. Kvanta, A. 1994. Expression and secretion of transforming growth factor-β in transformed and nontransformed retinal pigment epithelial cells. Ophthalmic Res. 26:361.
59. Torigoe, S., D. E. Campbell, F. Torigoe, S. Michelson, and S. E. Starr. 1993. Cytofluorographic analysis of effects of interferons on expression of human cytomegalovirus proteins. J. Virol. Methods 45:219.
60. Akaike, T., Y. Noguchi, S. Ijiri, K. Setoguchi, M. Suga, Y. M. Zheng, B. Dietzschold, and H. Maeda. 1996. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93:2448.
61. Croen, K. D. 1993. Evidence for antiviral effect of nitric oxide: inhibition of herpes simplex virus type I replication. J. Clin. Invest. 91:2446.
62. Michelson, S., J. Alcami, S. J. Kim, D. Danielpour, F. Bachelerie, L. Picard, C. Bessia, C. Paya, and J. L. Virelizier. 1994. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor β1. J. Virol. 68:5730.
63. Kutty, R. K., G. Kutty, J. J. Hooks, B. Wiggert, and C. N. Nagineni. 1995. Transforming growth factor-β inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 215:386.
64. Miller, D. M., B. M. Rahill, J. M. Boss, M. D. Lairmore, J. E. Durbin, W. J. Waldman, and D. D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class Ii expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675.
65. Faure, V., Y. Courtois, and O. Goureau. 1997. Inhibition of inducible nitric oxide synthase expression by interferons a and β in bovine retinal pigmented epithelial cells. J. Biol. Chem. 272:32169.
66. Wills, M. R., A. J. Carmichael, K. Mynard, X. Jin, M. P. Weekes, B. Plachter, and J. G. Sissons. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70:7569.